Page 1390 - Problem-Based Feline Medicine

1382 DRUG INDEX

Frequency (h) b 18 mnths for wk 48–72 h 4 days 24 × 24 2 wk, then 24 for 48 48 2–4 h every 30 seconds until 24 24, in a protocol 8 8 time of 6 at 3 × cylcophosphamide follow with treatment dose(24 hour repeat infusion) 12–24 4–6 12

Route a PO IV, IM, IP PO PO PO PO PO IM IM local epidural PO PO IV IV PO, IV, SC, IM in moistened food PO slowly IV to effect IV PO

Dose 2.5 mg/cat 5–30 ml/cat 0.1 mg/kg 0.1 mg/cat 0.05 mg/kg 0.05 mg/kg 2 mg/m 2 1–5 mg/kg 2.2–4.4 mg/kg local infiltration as needed 0.5 ml (1–5 ml) of 2% or 50 mg/m 2 2 mg/kg 20 mg/kg 40 mg/kg 40% of cyclophos- phamide dose 2–4 g/cat 0.325–0.65 mg/kg 0.01–0.10 mg/kg or 10 mg in 250 ml 5% dextrose 2 mg/kg

Chemical contraception Anti-inflammatory Ovarian carcinoma, multiple myeloma, lymphoreticular neoplasms, osteosarcoma, pulmonary neoplasms FIP, chronic lymphocytic leukemia Chronic myelocytic leukemia, Susceptible bacterial infections, Hemorrhagic cystitis associated With cyclophosphamide during shock support Hyperglycemia (non-insulin- diabetes mellitus)

Indications (continued) Leishmaniasis Multiple myeloma mammary or Sedation Local analgesic lymphoma meningitis Laxative Bronchodilation Vascular dependent

Meglumine antimonate 6–Mercaptopurine Metaproterenol sulfate

Continued Drug Meloxicam Melphan Mepiridine Mepivacaine Meropenem Mesna Metamucil Metaraminol Metformin